The assessment of refill compliance using pharmacy records: Methods, validity, and applications

Journal of Clinical Epidemiology

Volumn 50, Issue 1, 1997, Pages 105-116

  Steiner, John F ^a   Prochazka, Allan V ^a,b  

^a UNIVERSITY OF COLORADO   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Community pharmacy; Drug prescriptions; Drug utilization; Patient compliance

Indexed keywords

ARTICLE; CLINICAL FEATURE; COMPUTER SYSTEM; DRUG BLOOD LEVEL; DRUG DOSE; DRUG EFFECT; EPIDEMIOLOGY; HEALTH SERVICES RESEARCH; HUMAN; METHODOLOGY; PATIENT COMPLIANCE; PHARMACY; POPULATION RESEARCH; PRESCRIPTION; PRIORITY JOURNAL;

AUSTRALIA; DRUG MONITORING; FEMALE; FINLAND; GREAT BRITAIN; HEALTH STATUS; HUMANS; MALE; PATIENT COMPLIANCE; PHARMACEUTICAL PREPARATIONS; PHARMACOKINETICS; PHARMACY; PREDICTIVE VALUE OF TESTS; PRESCRIPTIONS, DRUG; RECORDS; TREATMENT OUTCOME; UNITED STATES;

EID: 0031046049     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-4356(96)00268-5     Document Type: Article

References (61)

1. 1. Green LW, Mullen PD, Friedman RB. Epidemiological and community approaches to patient compliance. In: Cramer JA, Spilker B, Eds. Patient Compliance in Medical Practice and Clinical Trials. New York: Raven Press; 1991: 373-386.
2. 2. Feinstein AR. "Compliance bias" and the interpretation of therapeutic trials. In: Haynes RB, Taylor DW, Sackett DL, Eds. Compliance in Health Care. Baltimore: Johns Hopkins University Press; 1979: 309-322.
3. 3. Macharia WM, Leon G, Rowe BH, Stephenson BJ, Haynes RB. An overview of interventions to improve compliance with appointment keeping for medical services. JAMA 1992; 267: 1813-1817.
4. 4. Beardon PHG, McGilchrist MM, McKendrick AD, McDevitt DG, MacDonald TM. Primary non-compliance with prescribed medication in primary care. Brit Med J 1993; 307: 846-848.
5. 5. Vander Stichele R. Measurement of patient compliance and the interpretation of randomized clinical trials. Eur J Clin Pharmacol 1991; 41: 27-35.
6. 6. Rudd P. In search of the gold standard for compliance measurement. Arch Intern Med 1979; 139: 627-628.
7. 7. Rudd P, Ahmed S, Zachary V, Barton C, Bonduelle D. Improved compliance measures: Applications in an ambulatory hypertensive drug trial. Clin Pharmacol Ther 1990; 48: 676-685.
8. 8. Stephenson BJ, Rowe BH, Haynes RB, Macharia WM, Leon G. Is this patient taking the treatment as prescribed? JAMA 1993; 269: 2779-2781.
9. 9. Steiner JF, Koepsell TD, Fihn SD, Inui TS. A general method of compliance assessment using centralized pharmacy records: Description and validation. Med Care 1988; 26: 814-823.
10. 10. Meyer TJ, Van Kooten D, Marsh S, Prochazka AV. Reduction of polypharmacy by feedback to clinicians. J Gen Intern Med 1991; 6: 133-136.
11. 11. Steiner JF, Fihn SD, Blair B, Inui TS. Appropriate reductions in compliance among well-controlled hypertensive patients. J Clin Epidemiol 1991; 44: 1361-1371.
12. 12. Steiner JF, Robbins LJ, Roth SC, Hammond WS. The effect of prescription size on acquisition of maintenance medications. J Gen Intern Med 1993; 8: 306-310.
13. 13. Porter AMW. Drug defaulting in a general practice. Brit Med J 1969; 1: 218-222.
14. 14. Roth HP, Caron HS, Hsi BP. Estimating a patient's compliance with his regimen. Am J Med Sci 1971; 262: 269-273.
15. 15. Solomon DK, Baumgartner RP, Glascock LM, Glascock SA, Briscoe ME, Billups NF. Use of medication profiles to detect potential therapeutic problems in ambulatory patients. Am J Hosp Pharm 1974; 31: 348-354.
16. 16. Wandless I, Mucklow JC, Smith A, Prudham D. Compliance with prescribed medicines: A study of elderly patients in the community. J Royal Coll Gen Prac 1979; 29: 391-396.
17. 17. Inui TS, Carter WB, Pecoraro RE, Pearlman RA, Dohan JJ. Variations in patient compliance with common long-term drugs. Med Care 1980; 18: 986-993.
18. 18. Brown DJ, Ellsworth A, Taylor JW. Identification of potentially noncompliant patients with a mailed medication refill reminder system. Contemp Pharm Pract 1980; 3: 244-248.
19. 19. Enlund H, Tuomilehto J, Turakka H. Patient report validated against prescription records tor measuring use of and compliance with antihypertensive drugs. Acta Med Scand 1981 ; 209: 271-275.
20. 20. Lambie DG, Johnson RH, Stanaway L. Prescribing patterns for epilepsy. N Z Med J 1981; 94: 15-19.
21. 21. Monson R, Bond CA, Schuna A. Role of the clinical pharmacist in improving drug therapy. Clinical pharmacists in outpatient therapy. Arch Intern Med 1981; 141: 1441-1444.
22. 22. Deyo RA, Inui TS, Sullivan B. Noncompliance with arthritis drugs: Magnitude, correlates, and clinical implications. J Rheumatol 1981; 8: 931-936.
23. 23. Enlund H. Measuring patient compliance in antihypertensive therapy - Some methodological aspects. J Clin Hosp Pharm 1982; 7: 43-51.
24. 24. Schultz RM, Gagnon JP. Patient behavior patterns regarding prescription refills. Contemp Pharm Pract 1982; 5: 150-155.
25. 25. Peterson GM, McLean S, Millingen KS. Determinants of patient compliance with anticonvulsant therapy. Epilepsia 1982; 23: 607-613.
26. 26. Bond CA, Monson R. Sustained improvement in drug documentation, compliance, and disease control. Four-year analysis of an ambulatory care model. Arch Intern Med 1984; 144: 1159-1162.
27. 27. DeTullio PL, Kirking DM, Arslanian C, Olson DE. Compliance measure development and assessment of theophylline therapy in ambulatory patients. J Clin Pharm Ther 1987; 12: 19-26.
28. 28. Weingarten MA, Cannon BS. Age as a major factor affecting adherence to medication for hypertension in a general practice population. Fam Practice 1988; 5: 294-296.
29. 29. Milanes F, Boza RA, Kaye J, Hanna G, Talcott V. Reporting the facts about compliance. V A Practitioner 1989; 6: 51-59.
30. 30. Maronde RF, Chan LS, Larsen FJ, Strandberg LR, Laventurier MF, Sullivan SR. Underutilization of antihypertensive drugs and associated hospitalisation. Med Care 1989; 27: 1159-1166.
31. 31. Psaty BM, Koepsell TD, Wagner EH, LoGerfo JP, Inui TS. The relative risk of incident coronary heart disease associated with recently stopping the use of beta-blockers. JAMA 1990; 263: 1653-1657.
32. 32. Elixhauser A, Eisen SA, Romeis JC, Homan SM. The effects of monitoring and feedback on compliance. Med Care 1990; 28: 882-893.
33. 33. Sclar DA, Chin A, Skaer TL, Okamoto MP. Nakahiro RK, Gill MA. Effect of health education in promoting prescription refill compliance among patients with hypertension. Clin Ther 1991; 13: 489-495.
34. 34. Sclar DA, Skaer TL, Chin A, Okamoto MP, Gill MA. Utility of a transdermal delivery system for antihypertensive therapy. Part 1. Am J Med 1991; 91: 1A-50S-56S.
35. 35. Sclar DA, Skaer TL, Chin A, Okamoto MP, Gill MA. Utility of a transdermal delivery system for antihypertensive therapy. Part 2. Am J Med 1991; 91: 1A-57S-60S.
36. 36. Katon W, Von Korff M, Lin E, Bush T, Ormel J. Adequacy and duration of antidepressant treatment in primary care. Med Care 1992; 30: 67-76.
37. 37. Hamilton RA, Briceland LL. Use of prescription-refill records to assess patient compliance. Am J Hosp Pharm 1992; 49: 1691-1696.
38. 38. Stergachis A, Sheingold S, Luce BR, Psaty BM, Revicki DA. Medical care and cost outcomes after pentoxifylline treatment for peripheral arterial disease. Arch Intern Med 1992; 152: 1220-1224.
39. 39. Gurwitz JH, Glynn RJ, Monane M, Everitt DE, Gilden D, Smith N, Avorn J. Treatment for glaucoma: Adherence by the elderly. Am J Public Health 1993; 83: 711-716.
40. 40. Hawkins DW, Fiedler FP, Douglas HL, Eschbach RC. Evaluation of a clinical pharmacist in caring for hypertensive and diabetic patients. Am J Hosp Pharm 1979; 36: 1321-1325.
41. 41. Ascione FJ, Brown GH, Kirking DM. Evaluation of a medication refill reminder system for a community pharmacy. Patient Educ Couns 1985; 7: 157-165.
42. 42. Simkins CV, Wenzloff NJ. Evaluation of a computerized reminder system in the enhancement of patient medication refill compliance. Drug Intell Clin Pharm 1986; 20: 799-802.
43. 43. Simon GE, Von Korff M, Wagner EH, Barlow W. Patterns of antidepressant use in community practice. Gen Hosp Psychiatry 1993; 15: 399-408.
44. 44. Skaer TL, Sclar DA, Markowski DJ, Won JKH. Effect of value-added utilities on prescription refill compliance and Medicaid health care expenditures - A study of patients with non-insulin-dependent diabetes mellitus. J Clin Pharm Ther 1993; 18: 295-299.
45. 45. Halpern MT, Irwin DE, Brown RE, Clouse J, Hatziandreu EJ. Patient adherence to prescribed potassium supplement therapy. Clin Ther 1993; 15: 1133-1145.
46. 46. Monane M, Bohn RL, Gurwitz JH, Glynn RJ, Avorn J. Non-compliance with congestive heart failure therapy in the elderly. Arch Intern Med 1994; 154: 433-437.
47. 47. Kelloway JS, Wyatt RA, Adlis SA. Comparison of patients' compliance with prescribed oral and inhaled asthma medications. Arch Intern Med 1994; 154: 1349-1352.
48. 48. McCombs JS, Nichol MB, Newman CM, Sclar DA. The costs of interrupting antihypertensive drug therapy in a medical population. Med Care 1994; 32: 214-226.
49. 49. Furmaga EM. Pharmacist management of a hyperlipidemia clinic. Am J Hosp Pharm 1993; 50: 91-95.
50. 50. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986; 24: 67-74.
51. 51. Haynes RB, Taylor DW, Snow JC, Sackett DL. Annotated and indexed bibliography on compliance with therapeutic and preventive regimens. In: Haynes RB, Taylor DW, Sackett DL, Eds. Compliance in Health Care. Baltimore: Johns Hopkins University Press; 1979; 337-474.
52. 52. Cramer JA, Mattson RH, Prevey ML, Scheyer RD, Ouellette VL. How often is medication taken as prescribed? A novel assessment technique. JAMA 1989; 261: 3273-3277.
53. 53. Feinstein AR. Clinimetrics. New Haven, CT: Yale University Press; 1987.
54. 54. Johnson BF, Whelton A. A study design for comparing the effects of missing daily doses of antihypertensive drugs. Am J Therapeutics 1994; 1: 260-267.
55. 55. Guilleband J. Any questions. Brit Med J 1993; 307: 617.
56. 56. Shapiro S. The role of automated record linkage in the post-marketing surveillance of drug safety: A critique. Clin Pharmacol Ther 1989; 46: 371-386.
57. 57. Van Staa T, Abenhaim E, Leufkens H. A study of the effects of exposure misclassification due to the time-window design in pharmacoepidemiologic studies. J Clin Epidemiol 1994; 47: 183-189.
58. 58. Petri H, Leufkins H, Naus J, Silkens R, van Hessen P, Urquhart J. Rapid method for estimating the risk of acutely controversial side effects of prescription drugs. J Clin Epidemiol 1990; 43: 433-439.
59. 59. Siscovick DS, Raghunathan TE, Psaty BM, Koepsell TD, Wicklund KG, Lin X, et al. Diuretic therapy for hypertension and the risk of primary cardiac arrest. New Engl J Med 1994; 330: 1852-1857.
60. 60. Ray WA, Griffin MR, Schaffner W, Baugh DK, Melton LJ. Psychotropic drug use and the risk of hip fracture. New Engl J Med 1987; 316: 363-569.
61. 61. Feinstein AR. Clinical Epidemiology: The Architecture of Clinical Research. Philadelphia: W.B. Saunders; 1985.